FDA issued a Warning Letter to Cadila Healthcare Limited on 10/29/2019 for a later inspection.
483 Cadila Healthcare Aug 2013

483 Cadila Healthcare Aug 2013

Mural Gavini FDA, James Maclaughlin FDA$119.00 - Available Now

FDA investigators audited the Cadila Healthcare - Ahmedabad, India facility and issued inspectional observations (via FDA 483) on 19 Aug 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Aug 2013
  • Location: Ahmedabad, India
  • FEI: 3002984011
Add To Cart